Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Takeda
organization8 mentionslast seen Oct 8, 2026
A pharmaceutical company where Markus Zeitz is Head of Digital Quality.
Relationships 7
- Insilico Medicinepartners withTakeda98% confidence2 sources
- Takedapartners withDigital CMC Consortium93% confidence1 source
- Takedainvests inInsilico Medicine90% confidence1 source
- TakedacommercializesENHANZE90% confidence1 source
- Takedapartners withDigital CMC Consortium90% confidence1 source
- TakedaemploysMarkus Zeitz90% confidence1 source
- Takedapartners withHalozyme Therapeutics, Inc.85% confidence1 source
Relationship
Insilico Medicinepartners withTakeda
98% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireSep 30, 2026Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
out-licensing, co-development, and R&D collaborations with leading global partners, including Eli Lilly, Servier, Takeda, SK Biopharmaceuticals, Qilu Pharmaceutical, Hygtia Therapeutics, China Medical System (CMS), and Tenacia Biotechnology
- newsPR NewswireSep 17, 2026Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
out-licensing, co-development, and R&D collaborations with global partners, including Eli Lilly, Servier, Takeda